intravenous busulfan

DRUG2 trials

Sponsors

Alberta Health services, Institute of Hematology & Blood Diseases Hospital, China

Conditions

Acute Myeloid LeukemiaHematologic Malignancy

Phase 3

Twice-per-weekSelinexor, 2 Days Melphalan

Not yet recruitingNCT06613035

Institute of Hematology & Blood Diseases Hospital, ChinaAcute Myeloid Leukemia

Start: 2024-09-30End: 2027-09-30Target: 126Updated: 2024-09-25

Unknown Phase

Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

Alberta Health servicesHematologic Malignancy

Start: 1998-01-31End: 2010-12-31Target: 200Updated: 2012-01-19